Literature DB >> 23859989

MicroRNA regulation of integrins.

Weiguo Chen1, Mark C Harbeck, Wei Zhang, Jeffrey R Jacobson.   

Abstract

MicroRNAs (miRNAs) are a family of small RNAs that are ∼20 nucleotides in length and are nontranslated. To date, more than 700 miRNAs have been identified, and their involvement in many essential cellular processes is now apparent. By binding with target messenger RNAs (mRNA), miRNAs are able to regulate both mRNA stability and mRNA translational efficiency. Integrins are a family of transmembrane proteins that both regulate cell matrix interactions and serve as receptors that mediate intracellular signaling and a variety of cellular processes, including inflammatory responses, immunoresponses, and tumorigenesis. Integrin expression may also be regulated by miRNAs, which can also modulate integrin signaling and function. Integrins are heterodimer adhesion proteins comprised of an α and a β subunit. Cumulatively, there are 18 α subunits and 8 β subunits that can combine to form 24 distinct αβ receptor complexes. In addition, each integrin can be classified into 1 of 4 groups based on its extracellular binding ligand: collagen, laminin, RGD (Arg-Gly-Asp) or leukocyte-specific receptors. Collagen ligand integrins include integrins α1 and α2 subunits, known to be regulated by specific miRNAs. Among the laminin ligand integrins, there are no integrin α subunits known to be regulated by miRNA. As for the RGD ligand integrins, integrin α5 is the only α subunit found to be regulated by miRNAs (miR-31, miR-17-92 cluster, and miR-148 b). Finally, among the α subunits that comprise the leukocyte-specific receptor ligand integrins, integrins αD, αL, αM, and αX have shown regulation by different miRNAs. As for the integrin β subunits, regulation by miRNAs has been reported for all but β5 and β6 to date. However, computational predictions suggest that numerous miRNAs potentially regulate a variety of target integrins. These predictions will undoubtedly guide future investigations of mechanisms underlying integrin expression mechanism and may ultimately yield new therapeutic tools.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  BT-IC; MicroRNA; RGD; SLE; UTR; arginine-glycine-aspartine; breast tumor initiating cell; mRNA; messenger RNA; miRNA; systemic lupus erythematosus; untranslated terminus

Mesh:

Substances:

Year:  2013        PMID: 23859989      PMCID: PMC3825554          DOI: 10.1016/j.trsl.2013.06.008

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  41 in total

1.  Integrin β4 regulates SPARC protein to promote invasion.

Authors:  Kristin D Gerson; Jeffrey R Shearstone; V S R Krishna Maddula; Bruce E Seligmann; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 2.  Integrins as therapeutic targets.

Authors:  Simon L Goodman; Martin Picard
Journal:  Trends Pharmacol Sci       Date:  2012-05-25       Impact factor: 14.819

Review 3.  MicroRNAs in genetic disease: rethinking the dosage.

Authors:  Alexandra Henrion-Caude; Muriel Girard; Jeanne Amiel
Journal:  Curr Gene Ther       Date:  2012-08       Impact factor: 4.391

4.  Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin.

Authors:  Weiguo Chen; Saad Sammani; Sumegha Mitra; Shwu Fan Ma; Joe G N Garcia; Jeffrey R Jacobson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

5.  miR-31 is a broad regulator of β1-integrin expression and function in cancer cells.

Authors:  Katarzyna Augoff; Mitali Das; Katarzyna Bialkowska; Brian McCue; Edward F Plow; Khalid Sossey-Alaoui
Journal:  Mol Cancer Res       Date:  2011-08-29       Impact factor: 5.852

6.  miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis.

Authors:  Xiang Yu; Daniel M Cohen; Christopher S Chen
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

7.  miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.

Authors:  Qiaofei Liu; Miaomiao Zhang; Xingran Jiang; Zhiqian Zhang; Lingyun Dai; Siping Min; Xilong Wu; Qingsheng He; Jingyi Liu; Yuan Zhang; Zhujun Zhang; Rongcun Yang
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

Review 8.  Roles for microRNAs in conferring robustness to biological processes.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

9.  Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29.

Authors:  Monika Kwiecinski; Natalia Elfimova; Andrea Noetel; Ulrich Töx; Hans-Michael Steffen; Ulrich Hacker; Roswitha Nischt; Hans Peter Dienes; Margarete Odenthal
Journal:  Lab Invest       Date:  2012-05-07       Impact factor: 5.662

10.  Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction.

Authors:  Monika Kwiecinski; Andrea Noetel; Natalia Elfimova; Jonel Trebicka; Stephanie Schievenbusch; Ingo Strack; Levente Molnar; Melanie von Brandenstein; Ulrich Töx; Roswitha Nischt; Oliver Coutelle; Hans Peter Dienes; Margarete Odenthal
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

View more
  16 in total

1.  The miR-183/ItgA3 axis is a key regulator of prosensory area during early inner ear development.

Authors:  Priscilla Van den Ackerveken; Anaïs Mounier; Aurelia Huyghe; Rosalie Sacheli; Pierre-Bernard Vanlerberghe; Marie-Laure Volvert; Laurence Delacroix; Laurent Nguyen; Brigitte Malgrange
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  Association between polymorphisms of microRNA-binding sites in integrin genes and gastric cancer in Chinese Han population.

Authors:  Xingbo Song; Huiyu Zhong; Juan Zhou; Xuejiao Hu; Yi Zhou; Yuanxin Ye; Xiaojun Lu; Jun Wang; Binwu Ying; Lanlan Wang
Journal:  Tumour Biol       Date:  2014-12-04

Review 3.  Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.

Authors:  Thu H N Nguyen; Thanh T N Nguyen; Tran T M Nguyen; Le H M Nguyen; Luan H Huynh; Hoang N Phan; Hue T Nguyen
Journal:  Breast Cancer Res Treat       Date:  2022-09-09       Impact factor: 4.624

4.  Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.

Authors:  Jesse W Rowley; Stéphane Chappaz; Aurélie Corduan; Mark M W Chong; Robert Campbell; Amanda Khoury; Bhanu Kanth Manne; Jeremy G T Wurtzel; James V Michael; Lawrence E Goldfinger; Michele M Mumaw; Marvin T Nieman; Benjamin T Kile; Patrick Provost; Andrew S Weyrich
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

5.  Elucidating the role of plexin D1 in body fat distribution and susceptibility to metabolic disease using a zebrafish model system.

Authors:  James E N Minchin; John F Rawls
Journal:  Adipocyte       Date:  2017-08-09       Impact factor: 4.534

Review 6.  Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs.

Authors:  Cui Yang; Si-Dao Zheng; Hong-Jin Wu; Shao-Jun Chen
Journal:  Chin Med J (Engl)       Date:  2016-10-05       Impact factor: 2.628

Review 7.  Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing.

Authors:  Sabita N Saldanha; Kendra J Royston; Neha Udayakumar; Trygve O Tollefsbol
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

Review 8.  MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence.

Authors:  Yugang Zhuang; Hu Peng; Victoria Mastej; Weiguo Chen
Journal:  Mediators Inflamm       Date:  2016-11-24       Impact factor: 4.711

9.  Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells.

Authors:  Nunzia Di Maggio; Elisa Martella; Agne Frismantiene; Therese J Resink; Simone Schreiner; Enrico Lucarelli; Claude Jaquiery; Dirk J Schaefer; Ivan Martin; Arnaud Scherberich
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 10.  Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis.

Authors:  André Eduardo de Almeida Franzoi; Fernanda Subtil de Moraes Machado; Washigton Luiz Gomes de Medeiros Junior; Isabelle Pastor Bandeira; Wesley Nogueira Brandão; Marcus Vinicius Magno Gonçalves
Journal:  Heliyon       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.